Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Summary

This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and its metabolites in patients with mild renal impairment compared to their sex, age and weigh based healthy volunteer counterparts.

Timeline

Start

2007-10

Primary completion

2007-11

Completion

2007-11

Drugs

Indications